Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • virpericulosus
    Junior Member
    • Sep 2014
    • 3

    Where does my primer anneal?

    This seems like a dumb question, but I haven't been able to figure it out.

    I sequenced hemoglobin genes using primers I found online/literature. I found the mutation I was looking for, but I've tried locating the primer annealing site on NCBI and I can't figure out where it would bind.

    The gene is HBA2. The primers I used for exon 3 (where the mutation is) were:

    F: gaggatcacgcgggttg
    R: caggaaacagctatgacc (M13 reverse primer)

    Any routes besides NCBI people can suggest? I have the sequencing file that shows the sequencing starting... but I don't know if that really shows where the primer annealed.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    The forward primer maps to the second intron of both hba1 and hba2, which seems reasonable. You're not going to get good genomic DNA amplification with an M13 reverse primer. Are you actually sequencing genomic DNA or did you or someone else perform some subcloning?

    Comment

    • virpericulosus
      Junior Member
      • Sep 2014
      • 3

      #3
      We first used specific pcr primers to hba1 and hba2 and then sequenced using 3 pairs of primers.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      211 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      78 views
      0 reactions
      Last Post SEQadmin2  
      Working...